# EMBLAVEO

NDC: 0074-3878
Generic name: aztreonam and avibactam
Labeler / Manufacturer: AbbVie Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: POWDER, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20250207

FDA application: NDA217906

## Active ingredients

- AVIBACTAM: 42.3 mg/mL
- AZTREONAM: 127 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0074-3878"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0074-3878
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=be1a6c99-d4b3-46d7-9e99-6e5f9fab556a